Publications by authors named "K Jellema"
Background And Importance: Traumatic intracranial hemorrhage (tICH) after mild traumatic brain injury (mTBI) is not uncommon in the elderly. Often, these patients are admitted to the hospital for observation. The necessity of admission in the absence of clinically important intracranial injuries is however unclear.
View Article and Find Full Text PDFBackground/objective: A systematic review was conducted on the association between ethnicity and health-related quality of life in post-stroke populations.
Methods: In February 2024, a comprehensive search was conducted across several databases. Studies were included when they had at least 2 distinct ethnic post-stroke groups for comparison, along with the utilization of validated questionnaires to measure health-related quality of life.
Article Synopsis
- This study focuses on chronic subdural hematoma (CSDH) treatment, specifically how a portion of patients can resolve their condition without surgery, despite standard treatment typically involving an operation.
- Data were gathered from patients treated conservatively at three hospitals in the Netherlands, with a primary goal of identifying factors that allow patients to avoid further treatment within three months of diagnosis.
- Results show that 73% of patients did not need additional treatment, often having smaller hematoma volumes, indicating that further research is necessary to determine which patients truly need surgery versus those who can be treated conservatively.
Background And Objectives: The results of the ULTRA trial showed that ultra-early and short-term treatment with tranexamic acid (TXA) does not improve clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH). Possibly, the lack of a beneficial effect in all patients with aSAH is masked by antagonistic effects of TXA in certain subgroups. In this post hoc subgroup analysis, we investigated the effect of TXA on clinical outcome in patients with good-grade and poor-grade aSAH.
View Article and Find Full Text PDFArticle Synopsis
- The study compares two strategies for managing high blood pressure in patients with ischaemic strokes who are eligible for intravenous thrombolysis: an active blood-pressure-lowering strategy and a conservative, non-lowering approach.
- Conducted across 37 Dutch stroke centers, it involved eligible adults with elevated blood pressure and aimed to assess functional outcomes at 90 days, alongside secondary measures like complications and treatment timing.
- The trial started in January 2015 but was prematurely halted due to low patient enrollment and lack of funding.